Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Number of holders
-
18
-
Total 13F principal, excl. options
-
230M
-
Principal change
-
-196K
-
Total reported value, excl. options
-
$256M
-
Value change
-
-$517K
-
Number of buys
-
6
-
Number of sells
-
-7
-
Price
-
$1.11
Significant Holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q4 2021
19 filings reported holding 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 as of Q4 2021.
CARDLYTICS INC - NOTE 1.000% 9/1 has 18 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $230M of principal
.
Largest 10 bondholders include CITADEL ADVISORS LLC ($88.5M of principal), Linden Advisors LP ($65.6M of principal), WOLVERINE ASSET MANAGEMENT LLC ($40.8M of principal), CAPSTONE INVESTMENT ADVISORS, LLC ($10M of principal), GABELLI FUNDS LLC ($6.02M of principal), GUARDIAN POINT CAPITAL, LP ($5M of principal), LAZARD ASSET MANAGEMENT LLC ($5M of principal), 683 Capital Management, LLC ($2M of principal), DeepCurrents Investment Group LLC ($1.7M of principal), and Nicholas Investment Partners, LP ($1.39M of principal).
This table shows the top 18 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.